A Pilot Safety Trial of Prolonged (48 h) Infusion of the Dual Endothelin-Receptor Antagonist Tezosentan in Patients With Advanced Heart Failure

CHEST Journal ◽  
2001 ◽  
Vol 120 (2) ◽  
pp. 460-466 ◽  
Author(s):  
Guillermo Torre-Amione ◽  
Jean-Bernard Durand ◽  
Sheriff Nagueh ◽  
Mary T. Vooletich ◽  
Isaac Kobrin ◽  
...  
Keyword(s):  
Heart Failure ◽  
Receptor Antagonist ◽  
Advanced Heart Failure ◽  
Endothelin Receptor Antagonist ◽  
Endothelin Receptor

The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure

2001 ◽  
Vol 142 (2) ◽  
pp. 340-349 ◽  
Author(s):  
Christoph Schalcher ◽  
Gadi Cotter ◽  
Leonardo Reisin ◽  
Osmund Bertel ◽  
Isaac Kobrin ◽  
...  
Keyword(s):  
Heart Failure ◽  
Receptor Antagonist ◽  
Advanced Heart Failure ◽  
Endothelin Receptor Antagonist ◽  
Endothelin Receptor ◽  
Hemodynamic Parameters

scholarly journals Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist

2014 ◽  
Vol 9 (3) ◽  
pp. 490-498 ◽  
Author(s):  
Jamo Hoekman ◽  
Hiddo J. Lambers Heerspink ◽  
Giancarlo Viberti ◽  
Damien Green ◽  
Johannes F.E. Mann ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Receptor Antagonist ◽  
Endothelin Receptor Antagonist ◽  
Endothelin Receptor

scholarly journals Hemodynamic Effects of Tezosentan, an Intravenous Dual Endothelin Receptor Antagonist, in Patients With Class III to IV Congestive Heart Failure

Circulation ◽  
2001 ◽  
Vol 103 (7) ◽  
pp. 973-980 ◽  
Author(s):  
Guillermo Torre-Amione ◽  
James B. Young ◽  
Jean-Bernard Durand ◽  
Bykem Bozkurt ◽  
Douglas L. Mann ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Receptor Antagonist ◽  
Endothelin Receptor Antagonist ◽  
Endothelin Receptor ◽  
Class Iii ◽  
Hemodynamic Effects
Sign in / Sign up

Export Citation Format

Share Document